Nisamox 250 mg Tablets for Dogs
Nisamox 250 mg Tablets for Dogs
Authorised
- Potassium clavulanate
- Amoxicillin trihydrate
Product identification
Medicine name:
Nisamox 250 mg Tablets for Dogs
Active substance:
- Potassium clavulanate
- Amoxicillin trihydrate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Potassium clavulanate52.50/milligram(s)1.00Tablet
-
Amoxicillin trihydrate200.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CR02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Available in:
-
Spain
Package description:
- box containing 250 tablets (50 blister)
- box containing 20 tablets (5 blister)
- box containing 50 tablets (10 blister)
- bottle containing 250 tablets
- bottle containing 100 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
- Norbrook Laboratories (Ireland) Limited
Responsible authority:
- Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 1574 ESP
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0348/002
Concerned member states:
-
Italy
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 22/10/2025
Spanish (PDF)
Published on: 4/12/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 4/12/2025
